Studies of PD-L1 assays in non-small cell lung cancer (NSCLC) revealed clone 22C3 stains PD-L1 at a higher frequency on tumor vs immune cells21–24 whereas clone SP142 stains immune cells at a higher level compared to tumor cells. This evidence concerns the gene CD274 and neoplasm.